FindTrial
Sign In

Association between familial patent foramen ovale and cryptogenic stroke

Association between familial patent foramen ovale and cryptogenic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062418
Enrollment
Unknown
Registered
2022-08-05
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PFO and stroke

Interventions

Positive / negative group of patent foramen ovale in natural population screening:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 3-65 years old, gender unlimited (female non pregnancy); 2. In line with the 2018 diagnostic criteria of the Chinese guidelines for the diagnosis and treatment of ischemic stroke, cerebral infarction was further classified by TOAST classification; 3. No previous history of serious heart disease.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling to accept data registration or transthoracic echocardiography contrast echocardiography; 2. Unable to cooperate with the completion of Valsalva mover; 3. Other congenital heart diseases (such as atrial septal defect, ventricular septal defect, etc.) were found by transthoracic echocardiography.

Design outcomes

Primary

MeasureTime frame
Genomics;—

Secondary

MeasureTime frame
Onset age;Stroke manifestations;Medication;Cranial MRI;—

Countries

China

Contacts

Public ContactLei Chen

West China Hospital, Sichuan University

leilei_25@126.com+86 18980605819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026